In our large experience, patients treated with DEB for ISR-PCI have higher baseline risk and sustained increased MACE rates compared with DES ISR-PCI patients. After adjustment for confounding variables, clinical outcomes are similar between the groups at 1 year after PCI.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- end stage renal disease
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- coronary artery bypass grafting
- prognostic factors
- heart failure
- patient reported outcomes
- left ventricular
- insulin resistance